The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nimotuzumab plus paclitaxel and cisplatin as 1st line treatment for unresectable esophageal squamous cell carcinoma: Long term follow-up of survival in a phase II study.
 
Xiaodong Zhang
No Relationships to Disclose
 
Jun Jia
No Relationships to Disclose
 
Ming Lu
No Relationships to Disclose
 
Xicheng Wang
No Relationships to Disclose
 
Jifang Gong
No Relationships to Disclose
 
Jie Li
No Relationships to Disclose
 
Jian Li
No Relationships to Disclose
 
Yan Li
No Relationships to Disclose
 
Xiaotian Zhang
No Relationships to Disclose
 
Zhihao Lu
No Relationships to Disclose
 
Jing Yu
No Relationships to Disclose
 
Zhiwei Sun
No Relationships to Disclose
 
Ying Yang
No Relationships to Disclose
 
Lin Shen
No Relationships to Disclose